These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 21755989)

  • 1. Lessons learned from molecular scaffold analysis.
    Hu Y; Stumpfe D; Bajorath J
    J Chem Inf Model; 2011 Aug; 51(8):1742-53. PubMed ID: 21755989
    [No Abstract]   [Full Text] [Related]  

  • 2. The design, annotation, and application of a kinase-targeted library.
    Xi H; Lunney EA
    Methods Mol Biol; 2011; 685():279-91. PubMed ID: 20981529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of Free-Wilson selectivity analysis for combinatorial library design.
    Sciabola S; Stanton RV; Johnson TL; Xi H
    Methods Mol Biol; 2011; 685():91-109. PubMed ID: 20981520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diversity-oriented synthesis; a spectrum of approaches and results.
    Spandl RJ; Bender A; Spring DR
    Org Biomol Chem; 2008 Apr; 6(7):1149-58. PubMed ID: 18362950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinase inhibitor data modeling and de novo inhibitor design with fragment approaches.
    Vieth M; Erickson J; Wang J; Webster Y; Mader M; Higgs R; Watson I
    J Med Chem; 2009 Oct; 52(20):6456-66. PubMed ID: 19791746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design strategies for protein kinase inhibitors.
    Parang K; Sun G
    Curr Opin Drug Discov Devel; 2004 Sep; 7(5):617-29. PubMed ID: 15503864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping Biological Activities to Different Types of Molecular Scaffolds: Exemplary Application to Protein Kinase Inhibitors.
    Dimova D; Bajorath J
    Methods Mol Biol; 2018; 1825():327-337. PubMed ID: 30334211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors paradoxically prime kinases.
    Frye SV; Johnson GL
    Nat Chem Biol; 2009 Jul; 5(7):448-9. PubMed ID: 19465930
    [No Abstract]   [Full Text] [Related]  

  • 9. Sequence-based protein kinase inhibition: applications for drug development.
    Wexler ID; Niv MY; Reuveni H
    Biotechniques; 2005 Oct; 39(4):575-6. PubMed ID: 16235571
    [No Abstract]   [Full Text] [Related]  

  • 10. Fragment-based approaches to the discovery of kinase inhibitors.
    Mortenson PN; Berdini V; O'Reilly M
    Methods Enzymol; 2014; 548():69-92. PubMed ID: 25399642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of targeted libraries against the human Chk1 kinase using PGVL Hub.
    Peng Z; Hu Q
    Methods Mol Biol; 2011; 685():321-36. PubMed ID: 20981531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pharmacophore map of small molecule protein kinase inhibitors.
    McGregor MJ
    J Chem Inf Model; 2007; 47(6):2374-82. PubMed ID: 17941626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knowledge-based design of 7-azaindoles as selective B-Raf inhibitors.
    Tang J; Hamajima T; Nakano M; Sato H; Dickerson SH; Lackey KE
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4610-4. PubMed ID: 18662874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of trisubstituted imidazole derivatives as inhibitors of p38alpha mitogen-activated protein kinase.
    Kim DK; Lim JH; Lee JA; Dewang PM
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4006-10. PubMed ID: 18571921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for the NMR-based identification and optimization of allosteric protein kinase inhibitors.
    Jahnke W; Blommers MJ; Fernández C; Zwingelstein C; Amstutz R
    Chembiochem; 2005 Sep; 6(9):1607-10. PubMed ID: 16028302
    [No Abstract]   [Full Text] [Related]  

  • 16. Substituted 2-arylbenzothiazoles as kinase inhibitors: hit-to-lead optimization.
    Tasler S; Müller O; Wieber T; Herz T; Pegoraro S; Saeb W; Lang M; Krauss R; Totzke F; Zirrgiebel U; Ehlert JE; Kubbutat MH; Schächtele C
    Bioorg Med Chem; 2009 Sep; 17(18):6728-37. PubMed ID: 19692247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The synergy between combinatorial chemistry and high-throughput screening.
    Diller DJ
    Curr Opin Drug Discov Devel; 2008 May; 11(3):346-55. PubMed ID: 18428088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and SAR studies of potent imidazopyridine anticoccidial agents.
    Liang GB; Qian X; Feng D; Fisher M; Brown CM; Gurnett A; Leavitt PS; Liberator PA; Misura AS; Tamas T; Schmatz DM; Wyvratt M; Biftu T
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3558-61. PubMed ID: 17475489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular recognition of protein kinase binding pockets for design of potent and selective kinase inhibitors.
    Liao JJ
    J Med Chem; 2007 Feb; 50(3):409-24. PubMed ID: 17266192
    [No Abstract]   [Full Text] [Related]  

  • 20. CHI's Fourth Annual Drug Discovery Chemistry Conference. Kinase inhibitor chemistry: charting the chemical space. 7-8 April 2009, San Diego, CA, USA.
    Seneci P
    IDrugs; 2009 Jun; 12(6):358-62. PubMed ID: 19517315
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.